Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. clinical trial (NCT02087332). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Britomar compare to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. clinical trial (NCT02087332). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from either treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. clinical trial (NCT02087332). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. clinical trial (NCT02087332). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. clinical trial (NCT02087332). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my current medications be affected if I join this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. clinical trial (NCT02087332). Contact the study team or your healthcare provider for specific answers.

Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.

What this study is about

Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.

What this study is about